OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 58 filers reported holding OYSTER PT PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,032,000 | -71.8% | 260,553 | -55.7% | 0.01% | -71.4% |
| Q4 2021 | $10,733,000 | +103.8% | 587,835 | +32.2% | 0.04% | +84.2% |
| Q3 2021 | $5,267,000 | -17.5% | 444,489 | +19.7% | 0.02% | -17.4% |
| Q2 2021 | $6,382,000 | -6.0% | 371,289 | 0.0% | 0.02% | -20.7% |
| Q1 2021 | $6,787,000 | +100.9% | 371,289 | +106.8% | 0.03% | +81.2% |
| Q4 2020 | $3,378,000 | +45.9% | 179,524 | +63.6% | 0.02% | +33.3% |
| Q3 2020 | $2,316,000 | -18.3% | 109,724 | +11.8% | 0.01% | -25.0% |
| Q2 2020 | $2,835,000 | -14.5% | 98,177 | +3.6% | 0.02% | -23.8% |
| Q1 2020 | $3,316,000 | – | 94,763 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 2,768,586 | $32,226,000 | 14.34% |
| Paradigm Biocapital Advisors LP | 987,698 | $11,497,000 | 3.04% |
| NEA Management Company, LLC | 5,925,287 | $68,970,000 | 1.99% |
| KPCB XIV Associates, LLC | 367,987 | $4,283,000 | 1.61% |
| Telemark Asset Management, LLC | 787,026 | $9,161,000 | 0.81% |
| COWEN AND COMPANY, LLC | 509,794 | $5,934,000 | 0.57% |
| RTW INVESTMENTS, LP | 2,058,504 | $23,961,000 | 0.50% |
| ACT CAPITAL MANAGEMENT, LLC | 13,500 | $157,000 | 0.17% |
| Wildcat Capital Management, LLC | 36,847 | $429,000 | 0.11% |
| Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $12,101,000 | 0.11% |